The Viral Vector Core (VVC) is a driving engine of gene therapy research at the GTC. The core uses cutting-edge technologies to create and produce a variety of high quality viral vectors. The goal of the VVC is to provide investigators at UMMS and other institutions with the most suitable and efficient gene transfer vectors for their research applications.
We produce more than 900 rAAV vector batches a year, supporting UMMS investigators as well as external needs from academia and industry around the world.
VVC is also in the preliminary planning stage for a human applications GMP facility to produce clinical grade viral vectors. More details will be added as this facility becomes operational.
"Quality and great turnaround time at a competitive price."
Viral Vector Core has not received any endorsements.